Candel Therapeutics, Inc. (CADL) Financials

CADL Assets vs Liabilities

DateAssetsLiabilities
Sept. 30, 2026 211.1 million 79.5 million
June 30, 2026 208.1 million 82.0 million
March 31, 2026 201.9 million 63.9 million
Dec. 31, 2025 125.2 million 73.3 million

CADL Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2026 -23.3 million 2.7 million
June 30, 2026 -17.3 million 2.9 million
March 31, 2026 -18.7 million 1.5 million
Dec. 31, 2025 -11.0 million 1.3 million

CADL Net Income

No data available :(

CADL Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2026 203.1 million 1.1 million 1.6 million
June 30, 2026 201.6 million 47.8 million 1.7 million
March 31, 2026 194.8 million 1.3 million 1.8 million
Dec. 31, 2025 119.7 million 1.5 million 1.9 million

CADL Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2026 77.4 million
June 30, 2026 74.1 million
March 31, 2026 62.4 million
Dec. 31, 2025 54.9 million

CADL Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2026 141000 15.4 million 7.4 million -
June 30, 2026 69000 19.8 million 6.9 million -
March 31, 2026 675000 9.8 million 6.4 million -
Dec. 31, 2025 409000 11.0 million 4.7 million -

CADL Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2026 - 200000
June 30, 2026 - -
March 31, 2026 - 149000
Dec. 31, 2025 - 163000

CADL

Price: $4.96

52 week price:
4.35
14.00

Earnings Per Share: -1.53 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 14500

Market Capitalization: 423.6 million

Links: